Target Corporation (FRA:DYH)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Market Capitalization	39,262	60,797	62,244	71,455	93,434	74,739
Market Cap Growth	-42.52%	-2.32%	-12.89%	-23.52%	25.01%	47.66%
Enterprise Value	53,619	76,593	78,584	88,463	102,155	82,161
Last Close Price	85.60	129.40	126.40	140.71	171.82	132.81
PE Ratio	10.64	15.45	16.23	27.90	15.02	20.77
PS Ratio	0.42	0.59	0.63	0.71	0.98	0.97
PB Ratio	2.98	4.31	5.00	6.91	8.13	6.28
P/TBV Ratio	2.98	4.50	5.25	7.33	8.57	6.59
P/FCF Ratio	-	14.12	17.61	-	20.53	11.52
P/OCF Ratio	-	8.58	7.79	19.31	12.09	8.62
EV/Sales Ratio	0.58	0.75	0.79	0.88	1.08	1.07
EV/EBITDA Ratio	6.44	9.13	9.75	14.42	9.74	10.97
EV/EBIT Ratio	10.47	13.87	14.37	24.25	12.58	15.09
EV/FCF Ratio	17.20	17.79	22.23	-	22.44	12.66
Debt / Equity Ratio	1.30	1.36	1.46	1.71	1.28	1.05
Debt / EBITDA Ratio	2.03	2.13	2.13	2.69	1.36	1.61
Debt / FCF Ratio	5.51	4.44	5.15	-	3.24	1.92
Asset Turnover	1.90	1.88	1.98	2.04	2.02	1.99
Inventory Turnover	6.15	6.21	6.13	6.01	6.11	6.74
Quick Ratio	0.15	0.30	0.27	0.20	0.34	0.48
Current Ratio	0.94	0.94	0.91	0.92	0.99	1.03
Return on Equity (ROE)	29.08%	29.12%	33.55%	23.11%	50.95%	33.25%
Return on Assets (ROA)	6.64%	6.34%	6.78%	4.62%	10.78%	8.79%
Return on Capital (ROIC)	10.83%	10.61%	11.62%	8.29%	19.25%	14.92%
Return on Capital Employed (ROCE)	15.90%	15.50%	16.40%	11.70%	28.30%	21.20%
Earnings Yield	9.40%	6.47%	6.16%	3.58%	6.66%	4.81%
FCF Yield	7.94%	7.08%	5.68%	-1.95%	4.87%	8.68%
Dividend Yield	4.50%	3.30%	3.20%	2.59%	1.65%	1.66%
Payout Ratio	48.94%	50.01%	48.60%	66.04%	22.29%	30.75%
Buyback Yield / Dilution	0.67%	0.22%	0.41%	5.68%	2.51%	1.98%
Total Shareholder Return	5.17%	3.52%	3.60%	8.28%	4.16%	3.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.